{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:47:58Z","timestamp":1791776878852,"version":"4.3.4"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:p>\n            Recently, we demonstrated that in rats treated chronically with aldosterone and salt, severe tubulointerstitial fibrosis is associated with the activation of mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinases (ERK1\/2). Here, we investigated whether aldosterone stimulates collagen synthesis via ERK1\/2-dependent pathways in cultured rat renal fibroblasts. Gene expression of mineralocorticoid receptor (MR) and types I, II, III, and IV collagen was measured by real-time polymerase chain reaction (PCR). MR protein expression and ERK1\/2 activity were evaluated by Western blotting analysis with anti-MR and anti\u2013phospho-ERK1\/2 antibodies, respectively. Collagen synthesis was determined by [\n            <jats:sup>3<\/jats:sup>\n            H]-proline incorporation. Significant levels of MR mRNA and protein expression were observed in rat renal fibroblasts. Treatment with aldosterone (0.1 to 10 nmol\/L) increased ERK1\/2 phosphorylation in a concentration-dependent manner with a peak at 5 minutes. Aldosterone (10 nmol\/L) also increased the mRNA levels of types I, III, and IV collagen at 36 hours but had no effect on the type II collagen mRNA level. [\n            <jats:sup>3<\/jats:sup>\n            H]-proline incorporation was significantly increased by aldosterone in both the medium and cell layer at 48 hours. Aldosterone-induced ERK1\/2 phosphorylation was markedly attenuated by pretreatment with eplerenone (10 \u03bcmol\/L), a selective MR antagonist, or PD98059 (10 \u03bcmol\/L), a specific inhibitor of MAPK kinase\/ERK kinase, which is the upstream activator of ERK1\/2. In addition, both eplerenone and PD98059 prevented the aldosterone-induced increases in types I, III, and IV collagen mRNA and [\n            <jats:sup>3<\/jats:sup>\n            H]-proline incorporation. These results suggest that aldosterone stimulates collagen gene expression and synthesis via MR-mediated ERK1\/2 activation in renal fibroblasts, which may contribute to the progression of aldosterone-induced tubulointerstitial fibrosis.\n          <\/jats:p>","DOI":"10.1161\/01.hyp.0000174593.88899.68","type":"journal-article","created":{"date-parts":[[2005,8,9]],"date-time":"2005-08-09T00:25:48Z","timestamp":1123547148000},"page":"1039-1045","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":138,"title":["Aldosterone Stimulates Collagen Gene Expression and Synthesis Via Activation of ERK1\/2 in Rat Renal Fibroblasts"],"prefix":"10.1161","volume":"46","author":[{"given":"Yukiko","family":"Nagai","sequence":"first","affiliation":[{"name":"From Research Equipment Center (Y.N., A.M.), RI Research Center (K.M.), Second Department of Internal Medicine (G.-P.S., M.R., H.K., M.K.), and Department of Pharmacology (M.R., S.K., Y.A., A.N.), Kagawa Medical University, Kagawa, Japan; Department of Pharmacology (M.Y.), Nara Medical University School of Medicine, Nara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Miyata","sequence":"additional","affiliation":[{"name":"From Research Equipment Center (Y.N., A.M.), RI Research Center (K.M.), Second Department of Internal Medicine (G.-P.S., M.R., H.K., M.K.), and Department of Pharmacology (M.R., S.K., Y.A., A.N.), Kagawa Medical University, Kagawa, Japan; Department of Pharmacology (M.Y.), Nara Medical University School of Medicine, Nara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Ping","family":"Sun","sequence":"additional","affiliation":[{"name":"From Research Equipment Center (Y.N., A.M.), RI Research Center (K.M.), Second Department of Internal Medicine (G.-P.S., M.R., H.K., M.K.), and Department of Pharmacology (M.R., S.K., Y.A., A.N.), Kagawa Medical University, Kagawa, Japan; Department of Pharmacology (M.Y.), Nara Medical University School of Medicine, Nara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matlubur","family":"Rahman","sequence":"additional","affiliation":[{"name":"From Research Equipment Center (Y.N., A.M.), RI Research Center (K.M.), Second Department of Internal Medicine (G.-P.S., M.R., H.K., M.K.), and Department of Pharmacology (M.R., S.K., Y.A., A.N.), Kagawa Medical University, Kagawa, Japan; Department of Pharmacology (M.Y.), Nara Medical University School of Medicine, Nara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Kimura","sequence":"additional","affiliation":[{"name":"From Research Equipment Center (Y.N., A.M.), RI Research Center (K.M.), Second Department of Internal Medicine (G.-P.S., M.R., H.K., M.K.), and Department of Pharmacology (M.R., S.K., Y.A., A.N.), Kagawa Medical University, Kagawa, Japan; Department of Pharmacology (M.Y.), Nara Medical University School of Medicine, Nara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Miyatake","sequence":"additional","affiliation":[{"name":"From Research Equipment Center (Y.N., A.M.), RI Research Center (K.M.), Second Department of Internal Medicine (G.-P.S., M.R., H.K., M.K.), and Department of Pharmacology (M.R., S.K., Y.A., A.N.), Kagawa Medical University, Kagawa, Japan; Department of Pharmacology (M.Y.), Nara Medical University School of Medicine, Nara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyasu","family":"Kiyomoto","sequence":"additional","affiliation":[{"name":"From Research Equipment Center (Y.N., A.M.), RI Research Center (K.M.), Second Department of Internal Medicine (G.-P.S., M.R., H.K., M.K.), and Department of Pharmacology (M.R., S.K., Y.A., A.N.), Kagawa Medical University, Kagawa, Japan; Department of Pharmacology (M.Y.), Nara Medical University School of Medicine, Nara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Kohno","sequence":"additional","affiliation":[{"name":"From Research Equipment Center (Y.N., A.M.), RI Research Center (K.M.), Second Department of Internal Medicine (G.-P.S., M.R., H.K., M.K.), and Department of Pharmacology (M.R., S.K., Y.A., A.N.), Kagawa Medical University, Kagawa, Japan; Department of Pharmacology (M.Y.), Nara Medical University School of Medicine, Nara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youichi","family":"Abe","sequence":"additional","affiliation":[{"name":"From Research Equipment Center (Y.N., A.M.), RI Research Center (K.M.), Second Department of Internal Medicine (G.-P.S., M.R., H.K., M.K.), and Department of Pharmacology (M.R., S.K., Y.A., A.N.), Kagawa Medical University, Kagawa, Japan; Department of Pharmacology (M.Y.), Nara Medical University School of Medicine, Nara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Yoshizumi","sequence":"additional","affiliation":[{"name":"From Research Equipment Center (Y.N., A.M.), RI Research Center (K.M.), Second Department of Internal Medicine (G.-P.S., M.R., H.K., M.K.), and Department of Pharmacology (M.R., S.K., Y.A., A.N.), Kagawa Medical University, Kagawa, Japan; Department of Pharmacology (M.Y.), Nara Medical University School of Medicine, Nara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"From Research Equipment Center (Y.N., A.M.), RI Research Center (K.M.), Second Department of Internal Medicine (G.-P.S., M.R., H.K., M.K.), and Department of Pharmacology (M.R., S.K., Y.A., A.N.), Kagawa Medical University, Kagawa, Japan; Department of Pharmacology (M.Y.), Nara Medical University School of Medicine, Nara, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2003.10.047"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00701.x"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00929.x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.31.1.451"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.10.7711"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00707.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00277.x"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200109203451215"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000044937.95080.e9"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2004.01194.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.01.007"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000067463.13172.ea"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000118519.66430.22"},{"key":"e_1_3_2_14_2","first-page":"11","volume":"52","year":"2000","unstructured":"Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2000; 52: 11\u201334.","journal-title":"Pharmacol Rev"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000154681.38944.9a"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000108523.02100.E0"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-220375"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(87)90433-7"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00782a009"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000154365.30593.d3"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1994.1098"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00226785"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000131860.80444.ab"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.04.026"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.43.1.95"},{"key":"e_1_3_2_27_2","first-page":"557","volume":"68","year":"1993","unstructured":"Wiggins R, Goyal M, Merritt S, Killen PD. Vascular adventitial cell expression of collagen I messenger ribonucleic acid in anti-glomerular basement membrane antibody-induced crescentic nephritis in the rabbit. A cellular source for interstitial collagen synthesis in inflammatory renal disease. Lab Invest. 1993; 68: 557\u2013565.","journal-title":"Lab Invest"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.7.1652"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00157.x"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000140445.82949.54"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/me.2004-0469"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2005-0004"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00421.2002"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-220950"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000093188.53554.44"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000106135.02935.e1"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.0000174593.88899.68","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:24:42Z","timestamp":1715531082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.0000174593.88899.68"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1161\/01.HYP.0000174593.88899.68"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.0000174593.88899.68","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"2005-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-06-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-08-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}